Moreover, additional ocular disease models with likely involvement of GEF-H1 should be tested, such as other inflammatory models (e.g., conjunctivitis) or other common diseases affecting ocular endothelia and the RPE such as diabetic retinopathy and neovascular age-related macular degeneration (wet AMD). This evidence concerns the gene ARHGEF2 and diabetic retinopathy.